Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro

Springer Science and Business Media LLC - Tập 6 - Trang 1-10 - 2009
Jennifer L Strande1, Shane A Phillips1,2
1Division of Cardiovascular Medicine,, Medical College of Wisconsin, Milwaukee, USA
2Department of Physical Therapy, University of Illinois, Chicago, USA

Tóm tắt

Abdominal obesity is associated with pro-thrombotic and inflammatory states. Therefore, the purpose of this study was to examine the expression of thrombin receptors (PAR1 and PAR4) human adipose tissue and whether thrombin stimulates an inflammatory cytokine and growth factor profile in human adipose tissue. Human adipose tissue, isolated preadipocytes and differentiated adipocytes were used in this study. PAR1 and PAR4 mRNA and protein were detected by RT-PCR and immunoblot analysis in both adipose tissue and adipose microvessels. In separate studies, IL-1β, IL-6, MCP-1, TNF-α, IL-10, FGF-2, VEGF, and PDGF production were measured from adipose tissue (n = 5), adipocytes (n = 5), and preadipocytes (n = 3) supernatants with and without thrombin (1 or 10 U/ml; 24 hrs) treatment. Thrombin increased cytokine secretion of IL-1β, IL-6, MCP-1 and TNF-α and growth factor secretion of VEGF from adipocytes along with MCP-1 and VEGF from preadipocytes. The direct thrombin inhibitor lepirudin given in conjunction with thrombin prevented the thrombin-mediated increase in cytokine and growth factor secretion. Here we show that thrombin PAR1 and PAR4 receptors are present and that thrombin stimulates inflammatory cytokine generation and growth factor release in human adipose tissue and cells in vitro. These data suggest that thrombin may represent a molecular link between obesity and associated inflammation.

Tài liệu tham khảo

Vu TKHD, Wheaten VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991, 64: 1057-1068. Hollenberg MD: Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol Sci. 1996, 17: 3-6. Ossovskaya VS, Bunnett NW: Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004, 84: 579-621. Camerer E, Huang W, Coughlin SR: Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proceedings of the National Academy of Sciences. 2000, 97: 5255-5260. Cocks TM, Moffatt JD: Protease-activated receptors: sentries for inflammation?. Trends Pharmacol Sci. 2000, 21: 103-108. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N: Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev. 2005, 26: 1-43. Shankar R, de la Motte CA, Poptic EJ, DiCorleto PE: Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J Biol Chem. 1994, 269: 13936-13941. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A: Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 1994, 144: 975-985. Naldini A, Carney DH, Pucci A, Pasquali A, Carraro F: Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol. 2000, 35 (5): 255-259. Naldini A, Bernini C, Pucci A, Carraro F: Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes. J Leukoc Biol. 2005, 78: 736-744. Naldini A, Pucci A, Carney DH, Fanetti G, Carraro F: Thrombin Enhancement of Interleukin-1 Expression in Mononuclear Cells: Involvement of Proteinase-Activated Receptor-1. Cytokine. 2002, 20: 191-199. Maragoudakis ME, Kraniti N, Giannopoulou E, Alexopoulos K, Matsoukas J: Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists. Endothelium. 2001, 8: 195-205. Rauch BH, Scholz GA, Baumgartel-Allekotte D, Censarek P, Fischer JW, Weber A-A: Cholesterol Enhances Thrombin-Induced Release of Fibroblast Growth Factor-2 in Human Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2007, 27: e20-e25. Bian Z-M, Elner SG, Elner VM: Thrombin-Induced VEGF Expression in Human Retinal Pigment Epithelial Cells. Invest Ophthalmol Vis Sci. 2007, 48: 2738-2746. Marutsuka K, Hatakeyama K, Yamashita A, Asada Y: Role of Thrombogenic Factors in the Development of Atherosclerosis. J Atheroscler Thromb. 2005, 12 (1): 1-8. Reaven GM: Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993, 44: 121-131. Kohler HP: Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med Wkly. 2002, 132: 241-252. Romano M, Guagnano MT, Pacini G, Vigneri S, Falco A, Marinopiccoli M: Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab. 2003, 88: 5321-6. Godsland IF, Crook D, Proudler AJ, Stevenson JC: Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome. J Clin Endocrinol Metab. 2005, 90: 190-197. Sakkinen PA, Cushman M, Psaty BM, Kuller LH, Bajaj SP, Sabharwal AK: Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort. Thromb Haemost. 1998, 80: 134-139. Napoleone E, A DIS, Amore C, Baccante G, di Febbo C, Porreca E: Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?. J Thromb Haemost. 2007, 5: 1462-1468. Guagnano MT, Romano M, Falco A, Nutini M, Marinopiccoli M, Manigrasso MR: Leptin increase is associated with markers of the hemostatic system in obese healthy women. J Thromb Haemost. 2003, 1: 2330-2334. Fried SK, Moustaid-Moussa N: Culture of adipose tissue and isolated adipocytes. Methods Mol Biol. 2001, 155: 197-212. Hauner H, Skurk T, Wabitsch M: Cultures of human adipose precursor cells. Methods Mol Biol. 2001, 155: 239-247. Mangan DF, Wahl SM: Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol. 1991, 147: 3408-3412. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A: Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood. 2003, 102: 3224-3231. Fain JN: Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitamins & Hormones. 2006, Academic Press, 443-477. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004, 145: 2273-2282. Tsuchiya K, Yoshimoto T, Hirono Y, Tateno T, Sugiyama T, Hirata Y: Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-{kappa}B-dependent pathway in rat preadipocytes. Am J Physiol Endocrinol Metab. 2006, 291: E771-E778. Bruun JM, Lihn AS, Pedersen SB, Richelsen B: Monocyte Chemoattractant Protein-1 Release Is Higher in Visceral than Subcutaneous Human Adipose Tissue (AT): Implication of Macrophages Resident in the AT. J Clin Endocrinol Metab. 2005, 90: 2282-2289. Fain JN, Madan AK: Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int J Obes (Lond). 2005, 29 (11): 1299-1307. Fain JN, Madan AK: Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism. 2005, 54: 220-226. Claffey KP, Wilkison WO, Spiegelman BM: Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem. 1992, 267: 16317-16322. Gualillo O, Gonzalez-Juanatey JR, Lago F: The Emerging Role of Adipokines as Mediators of Cardiovascular Function: Physiologic and Clinical Perspectives. Trends in Cardiovascular Medicine. 2007, 17: 275-283. Gustafson B, Hammarstedt A, Andersson CX, Smith U: Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis. Arterioscler Thromb Vasc Biol. 2007, 27: 2276-83. Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V: Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis. Circ Res. 2003, 93: e88-e97.